Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析

◆英語タイトル:Carl Zeiss Meditec AG (AFX) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1123
◆発行会社(調査会社):GlobalData
◆発行日:2020年2月
◆ページ数:49
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Carl Zeiss Meditec AG (AFX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Carl Zeiss Meditec AG (Carl Zeiss Meditec), a division of Carl Zeiss AG, is an integrated medical technology company, which provides visualization solutions for minimally invasive surgical treatments. It operates in the fields of ophthalmology and neuro/ENT surgery. The company’s major products include surgical microscopes; intraocular lenses and consumables; optical coherence tomography systems; perimeters; fundus cameras; slit lamps; therapeutic and refractive lasers, optical biometers, ophthalmic microscopes, phacoemulsification/vitrectomy device, dental and surgical microscopes and intraoperative radiotherapy systems. It markets products directly and also through a network of distributors in Europe, the Americas and Asia-Pacific. Carl Zeiss Meditec is headquartered in Jena, Germany.

Carl Zeiss Meditec AG Key Recent Developments

May 07,2019: Efficient digital documentation of microscopic samples
May 06,2019: Continued profitable growth for Carl Zeiss Meditec
May 06,2019: Carl Zeiss Meditec: First half year 2018/2019
Apr 12,2019: Carl Zeiss Meditec reports further growth and defines expectations for fiscal year 2018/19
Apr 11,2019: Automated microscope for gentle and fast confocal 4D imaging

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Carl Zeiss Meditec AG – Key Facts
Carl Zeiss Meditec AG – Key Employees
Carl Zeiss Meditec AG – Key Employee Biographies
Carl Zeiss Meditec AG – Major Products and Services
Carl Zeiss Meditec AG – History
Carl Zeiss Meditec AG – Company Statement
Carl Zeiss Meditec AG – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Carl Zeiss Meditec AG – Business Description
Business Segment: Microsurgery
Overview
Performance
Business Segment: Ophthalmic Devices
Overview
Performance
Geographical Segment: Americas
Performance
Geographical Segment: APAC
Performance
Geographical Segment: EMEA
Performance
R&D Overview
Carl Zeiss Meditec AG – Corporate Strategy
Carl Zeiss Meditec AG – SWOT Analysis
SWOT Analysis – Overview
Carl Zeiss Meditec AG – Strengths
Carl Zeiss Meditec AG – Weaknesses
Carl Zeiss Meditec AG – Opportunities
Carl Zeiss Meditec AG – Threats
Carl Zeiss Meditec AG – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Carl Zeiss Meditec AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Carl Zeiss Meditec AG, Medical Equipment, Deals By Type, 2014 to YTD 2020
Carl Zeiss Meditec AG, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 07, 2019: Efficient digital documentation of microscopic samples
May 06, 2019: Continued profitable growth for Carl Zeiss Meditec
May 06, 2019: Carl Zeiss Meditec: First half year 2018/2019
Apr 12, 2019: Carl Zeiss Meditec reports further growth and defines expectations for fiscal year 2018/19
Apr 11, 2019: Automated microscope for gentle and fast confocal 4D imaging
Apr 09, 2019: New Multiplex mode for ZEISS Airyscan 2 enables fast and gentle confocal microscopy
Mar 14, 2019: OptiScan March 2019 presentation
Feb 11, 2019: Continued profitable growth for Carl Zeiss Meditec in the first three months of 2018/19
Jan 14, 2019: Carl Zeiss Meditec achieves strong revenue and EBIT growth in first three months 2018/19
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Carl Zeiss Meditec AG, Key Facts
Carl Zeiss Meditec AG, Key Employees
Carl Zeiss Meditec AG, Key Employee Biographies
Carl Zeiss Meditec AG, Major Products and Services
Carl Zeiss Meditec AG, History
Carl Zeiss Meditec AG, Subsidiaries
Carl Zeiss Meditec AG, Key Competitors
Carl Zeiss Meditec AG, Ratios based on current share price
Carl Zeiss Meditec AG, Annual Ratios
Carl Zeiss Meditec AG, Annual Ratios (Cont...1)
Carl Zeiss Meditec AG, Annual Ratios (Cont...2)
Carl Zeiss Meditec AG, Interim Ratios
Carl Zeiss Meditec AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Carl Zeiss Meditec AG, Medical Equipment, Deals By Type, 2014 to YTD 2020
Carl Zeiss Meditec AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Carl Zeiss Meditec AG, Performance Chart (2015 - 2019)
Carl Zeiss Meditec AG, Ratio Charts
Carl Zeiss Meditec AG, Medical Equipment, Deals By Year, 2014 to YTD 2020
Carl Zeiss Meditec AG, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Carl Zeiss Meditec AG (AFX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Marubeni Corporation (8002)-エネルギー分野:企業M&A・提携分析
    Summary Marubeni Corporation (Marubeni) is an integrated trading and investment business that operates through its domestic and overseas subsidiaries. It provides various products and commodities such as agri and marine products, chemicals, energy, metals and minerals, machinery, textiles, forest pr …
  • Aratana Therapeutics Inc (PETX):企業の財務・戦略的SWOT分析
    Summary Aratana Therapeutics Inc (Aratana) is a provider of pet care solutions. The company develops, commercializing and markets biopharmaceutical products for medical condition in cats and dogs. Its pipeline portfolio consists of small molecule pharmaceuticals and large molecule biologics that aim …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • Shenzhen Neptunus Interlong Bio-Technique Co Ltd (8329):企業の財務・戦略的SWOT分析
    Summary Shenzhen Neptunus Interlong Bio-Technique Co Ltd (Neptunus Interlong) is a provider of cytokine protein therapeutic drugs and preventive biological products. The company provides products such as recombinant human interferon a-2b for injection, recombinant human interleukin-2 for injection a …
  • Musgrave Group Plc:戦略・SWOT・企業財務分析
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Calian Group Ltd (CGY):企業の財務・戦略的SWOT分析
    Summary Calian Group Ltd (CTL), formerly Calian Technologies Ltd, is a diversified company that offers professional services in the areas of health, training, information technology, engineering and manufacturing. The company’s health division offers occupational health and other clinical services s …
  • Enusa Industrias Avanzadas, S.A., S.M.E:企業の戦略的SWOT分析
    Enusa Industrias Avanzadas, S.A., S.M.E - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Genetic Technologies Ltd (GTG):企業の製品パイプライン分析
    Summary Genetic Technologies Ltd (GTG) is a molecular diagnostic company that offers testing products and services to assess sporadic breast cancer risk and colorectal cancer risk assessment. It delivers the offerings by GeneType for breast cancer tests and GeneType test for colorectal cancer. GeneT …
  • Scripps Health:企業の戦略的SWOT分析
    Scripps Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Relievant MedSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Relievant MedSystems Inc (Relievant) is a medical device company developing new minimally-invasive solutions for the treatment of chronic low back pain (CLBP). The company's Intracept system, a minimally invasive procedure uses radiofrequency energy delivered through a small access tube into …
  • Tobishima Corporation:企業の戦略・SWOT・財務情報
    Tobishima Corporation - Strategy, SWOT and Corporate Finance Report Summary Tobishima Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Magyar Nemzeti Bank:企業の戦略的SWOT分析
    Magyar Nemzeti Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Macquarie Group Ltd
    Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Macquarie Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • MMC Norilsk Nickel:企業の戦略・SWOT・財務情報
    MMC Norilsk Nickel - Strategy, SWOT and Corporate Finance Report Summary MMC Norilsk Nickel - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Logitech International S.A.:企業の戦略・SWOT・財務情報
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Vietnam Prosperity Joint-Stock Commercial Bank (VPB):企業の財務・戦略的SWOT分析
    Vietnam Prosperity Joint-Stock Commercial Bank (VPB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s k …
  • NII Holdings, Inc.:戦略・SWOT・企業財務分析
    NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary NII Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • UCB Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary UCB Inc (UCB), a subsidiary of UCB SA, is a healthcare solutions provider that offers therapeutics. The company develops products with an emphasis on central nervous system and immunology therapeutic domains. Its products include cimzia, vimpat, keppra XR, neupro, tussionex pennkinetic, meta …
  • West Pharmaceutical Services Inc (WST):企業の財務・戦略的SWOT分析
    West Pharmaceutical Services Inc (WST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Russel Metals Inc:企業の戦略・SWOT・財務情報
    Russel Metals Inc - Strategy, SWOT and Corporate Finance Report Summary Russel Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆